-
1
-
-
84863986988
-
Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia
-
Surendran R.P., Visser M.E., Heemelaar S., et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. JIntern Med 2012, 272:185-196.
-
(2012)
JIntern Med
, vol.272
, pp. 185-196
-
-
Surendran, R.P.1
Visser, M.E.2
Heemelaar, S.3
-
2
-
-
20144375048
-
Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase
-
Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan bound lipoprotein lipase. JBiol Chem 2005, 280:21553-21560.
-
(2005)
JBiol Chem
, vol.280
, pp. 21553-21560
-
-
Merkel, M.1
Loeffler, B.2
Kluger, M.3
-
3
-
-
3142581525
-
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
-
Schaap F.G., Rensen P.C., Voshol P.J., et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. JBiol Chem 2004, 279:27941-27947.
-
(2004)
JBiol Chem
, vol.279
, pp. 27941-27947
-
-
Schaap, F.G.1
Rensen, P.C.2
Voshol, P.J.3
-
4
-
-
78650419569
-
-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1
-
-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1. Arterioscler Thromb Vasc Biol 2010, 30:2504-2509.
-
(2010)
Arterioscler Thromb Vasc Biol
, vol.30
, pp. 2504-2509
-
-
Shu, X.1
Nelbach, L.2
Weinstein, M.M.3
-
5
-
-
80055008025
-
Apolipoprotein A-V; a potent triglyceride reducer
-
Nilsson S.K., Heeren J., Olivecrona G., Merkel M. Apolipoprotein A-V; a potent triglyceride reducer. Atherosclerosis 2011, 219:15-21.
-
(2011)
Atherosclerosis
, vol.219
, pp. 15-21
-
-
Nilsson, S.K.1
Heeren, J.2
Olivecrona, G.3
Merkel, M.4
-
6
-
-
84878524779
-
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
-
Gonzales J.C., Gordts P.L., Foley E.M., Esko J.D. Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans. JClin Invest 2013, 123:2742-2751.
-
(2013)
JClin Invest
, vol.123
, pp. 2742-2751
-
-
Gonzales, J.C.1
Gordts, P.L.2
Foley, E.M.3
Esko, J.D.4
-
7
-
-
0141780842
-
Structure and interfacial properties of human apolipoprotein A-V
-
Weinberg R.B., Cook V.R., Beckstead J.A., et al. Structure and interfacial properties of human apolipoprotein A-V. JBiol Chem 2003, 278:34438-34444.
-
(2003)
JBiol Chem
, vol.278
, pp. 34438-34444
-
-
Weinberg, R.B.1
Cook, V.R.2
Beckstead, J.A.3
-
8
-
-
84867846073
-
Influence of apolipoprotein A-V on hepatocyte lipid droplet formation
-
Gao X., Forte T.M., Ryan R.O. Influence of apolipoprotein A-V on hepatocyte lipid droplet formation. Biochem Biophys Res Commun 2012, 427:361-365.
-
(2012)
Biochem Biophys Res Commun
, vol.427
, pp. 361-365
-
-
Gao, X.1
Forte, T.M.2
Ryan, R.O.3
-
9
-
-
1842864853
-
Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels
-
Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 2002, 11:3031-3038.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 3031-3038
-
-
Pennacchio, L.A.1
Olivier, M.2
Hubacek, J.A.3
Krauss, R.M.4
Rubin, E.M.5
Cohen, J.C.6
-
10
-
-
84861227604
-
The complex genetic basis of plasma triglycerides
-
Johansen C.T., Hegele R.A. The complex genetic basis of plasma triglycerides. Curr Atheroscler Rep 2012, 14:227-234.
-
(2012)
Curr Atheroscler Rep
, vol.14
, pp. 227-234
-
-
Johansen, C.T.1
Hegele, R.A.2
-
11
-
-
43149083460
-
Apoprotein A-V: an important regulator of triglyceride metabolism
-
Kluger M., Heeren J., Merkel M. Apoprotein A-V: an important regulator of triglyceride metabolism. JInherit Metab Dis 2008, 31:281-288.
-
(2008)
JInherit Metab Dis
, vol.31
, pp. 281-288
-
-
Kluger, M.1
Heeren, J.2
Merkel, M.3
-
12
-
-
40349113281
-
Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene
-
Priore Oliva C., Carubbi F., Schaap F.G., Bertolini S., Calandra S. Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene. JIntern Med 2008, 263:450-458.
-
(2008)
JIntern Med
, vol.263
, pp. 450-458
-
-
Priore Oliva, C.1
Carubbi, F.2
Schaap, F.G.3
Bertolini, S.4
Calandra, S.5
-
13
-
-
26444617632
-
Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment
-
Marcais C., Verges B., Charriere S., et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. JClin Invest 2005, 115:2862-2869.
-
(2005)
JClin Invest
, vol.115
, pp. 2862-2869
-
-
Marcais, C.1
Verges, B.2
Charriere, S.3
-
15
-
-
70350582764
-
Anovel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient
-
Okubo M., Ishihara M., Iwasaki T., et al. Anovel APOA5 splicing mutation IVS2+1g>a in a Japanese chylomicronemia patient. Atherosclerosis 2009, 207:24-25.
-
(2009)
Atherosclerosis
, vol.207
, pp. 24-25
-
-
Okubo, M.1
Ishihara, M.2
Iwasaki, T.3
-
16
-
-
33746576463
-
Anovel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia
-
Priore Oliva C., Tarugi P., Calandra S., et al. Anovel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. Atherosclerosis 2006, 188:215-217.
-
(2006)
Atherosclerosis
, vol.188
, pp. 215-217
-
-
Priore Oliva, C.1
Tarugi, P.2
Calandra, S.3
-
17
-
-
36949030808
-
Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient
-
Henneman P., Schaap F.G., Rensen P.C., van Dijk K.W., Smelt A.H. Estrogen induced hypertriglyceridemia in an apolipoprotein AV deficient patient. JIntern Med 2008, 263:107-108.
-
(2008)
JIntern Med
, vol.263
, pp. 107-108
-
-
Henneman, P.1
Schaap, F.G.2
Rensen, P.C.3
van Dijk, K.W.4
Smelt, A.H.5
-
18
-
-
53449102113
-
Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on invitro lipoprotein lipase activity and receptor binding
-
Dorfmeister B., Zeng W.W., Dichlberger A., et al. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on invitro lipoprotein lipase activity and receptor binding. Arterioscler Thromb Vasc Biol 2008, 28:1866-1871.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 1866-1871
-
-
Dorfmeister, B.1
Zeng, W.W.2
Dichlberger, A.3
-
19
-
-
51449114710
-
An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients
-
Pullinger C.R., Aouizerat B.E., Movsesyan I., et al. An apolipoprotein A-V gene SNP is associated with marked hypertriglyceridemia among Asian-American patients. JLipid Res 2008, 49:1846-1854.
-
(2008)
JLipid Res
, vol.49
, pp. 1846-1854
-
-
Pullinger, C.R.1
Aouizerat, B.E.2
Movsesyan, I.3
-
20
-
-
34249300603
-
Rare APOA5 mutations-clinical consequences, metabolic and functional effects: an ENID review
-
Talmud P.J. Rare APOA5 mutations-clinical consequences, metabolic and functional effects: an ENID review. Atherosclerosis 2007, 194:287-292.
-
(2007)
Atherosclerosis
, vol.194
, pp. 287-292
-
-
Talmud, P.J.1
-
21
-
-
84867898868
-
Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children
-
Lainka E., Neudorf U., Lohse P., et al. Incidence and clinical features of hyperimmunoglobulinemia D and periodic fever syndrome (HIDS) and spectrum of mevalonate kinase (MVK) mutations in German children. Rheumatol Int 2012, 32:3253-3260.
-
(2012)
Rheumatol Int
, vol.32
, pp. 3253-3260
-
-
Lainka, E.1
Neudorf, U.2
Lohse, P.3
-
22
-
-
0017202148
-
Astable, radioactive substrate emulsion for assay of lipoprotein lipase
-
Nilsson-Ehle P., Schotz M.C. Astable, radioactive substrate emulsion for assay of lipoprotein lipase. JLipid Res 1976, 17:536-541.
-
(1976)
JLipid Res
, vol.17
, pp. 536-541
-
-
Nilsson-Ehle, P.1
Schotz, M.C.2
-
23
-
-
0035812707
-
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
-
Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
-
(2001)
Science
, vol.294
, pp. 169-173
-
-
Pennacchio, L.A.1
Olivier, M.2
Hubacek, J.A.3
-
24
-
-
0041570292
-
Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis
-
Beckstead J.A., Oda M.N., Martin D.D., et al. Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis. Biochemistry 2003, 42:9416-9423.
-
(2003)
Biochemistry
, vol.42
, pp. 9416-9423
-
-
Beckstead, J.A.1
Oda, M.N.2
Martin, D.D.3
-
25
-
-
0024241875
-
Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture
-
Meredith M.J. Rat hepatocytes prepared without collagenase: prolonged retention of differentiated characteristics in culture. Cell Biol Toxicol 1988, 4:405-425.
-
(1988)
Cell Biol Toxicol
, vol.4
, pp. 405-425
-
-
Meredith, M.J.1
-
26
-
-
80054692396
-
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance
-
Bartelt A., Orlando P., Mele C., et al. Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. Diabetologia 2011, 54:2900-2910.
-
(2011)
Diabetologia
, vol.54
, pp. 2900-2910
-
-
Bartelt, A.1
Orlando, P.2
Mele, C.3
-
27
-
-
0026528213
-
Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism
-
Beil F.U., Fojo S.S., Brewer H.B., Greten H., Beisiegel U. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism. Eur J Clin Invest 1992, 22:88-95.
-
(1992)
Eur J Clin Invest
, vol.22
, pp. 88-95
-
-
Beil, F.U.1
Fojo, S.S.2
Brewer, H.B.3
Greten, H.4
Beisiegel, U.5
-
28
-
-
36148936452
-
Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study
-
Hallman D.M., Srinivasan S.R., Chen W., Boerwinkle E., Berenson G.S. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Metabolism 2006, 55:1574-1581.
-
(2006)
Metabolism
, vol.55
, pp. 1574-1581
-
-
Hallman, D.M.1
Srinivasan, S.R.2
Chen, W.3
Boerwinkle, E.4
Berenson, G.S.5
-
29
-
-
0037112882
-
Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides
-
Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002, 11:3039-3046.
-
(2002)
Hum Mol Genet
, vol.11
, pp. 3039-3046
-
-
Talmud, P.J.1
Hawe, E.2
Martin, S.3
-
30
-
-
70350759426
-
Modulation of phenotypic expression of APOA5 Q97X and L242P mutations
-
Charriere S., Cugnet C., Guitard M., et al. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations. Atherosclerosis 2009, 207:150-156.
-
(2009)
Atherosclerosis
, vol.207
, pp. 150-156
-
-
Charriere, S.1
Cugnet, C.2
Guitard, M.3
-
31
-
-
62449147005
-
Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan
-
Chang S.Y., Ko W.S., Kao J.T., et al. Association of single-nucleotide polymorphism 3 and c.553G>T of APOA5 with hypertriglyceridemia after treatment with highly active antiretroviral therapy containing protease inhibitors in HIV-infected individuals in Taiwan. Clin Infect Dis 2009, 48:832-835.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 832-835
-
-
Chang, S.Y.1
Ko, W.S.2
Kao, J.T.3
-
32
-
-
84859163245
-
Allelic and phenotypic spectrum of plasma triglycerides
-
Johansen C.T., Hegele R.A. Allelic and phenotypic spectrum of plasma triglycerides. Biochim Biophys Acta 2012, 1821:833-842.
-
(2012)
Biochim Biophys Acta
, vol.1821
, pp. 833-842
-
-
Johansen, C.T.1
Hegele, R.A.2
-
33
-
-
17144407867
-
Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study
-
Lai C.Q., Demissie S., Cupples L.A., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. JLipid Res 2004, 45:2096-2105.
-
(2004)
JLipid Res
, vol.45
, pp. 2096-2105
-
-
Lai, C.Q.1
Demissie, S.2
Cupples, L.A.3
-
34
-
-
25444519550
-
Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia
-
Yu Y., Wyszynski D.F., Waterworth D.M., et al. Multiple QTLs influencing triglyceride and HDL and total cholesterol levels identified in families with atherogenic dyslipidemia. JLipid Res 2005, 46:2202-2213.
-
(2005)
JLipid Res
, vol.46
, pp. 2202-2213
-
-
Yu, Y.1
Wyszynski, D.F.2
Waterworth, D.M.3
-
35
-
-
30844433948
-
Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks
-
Hodoglugil U., Tanyolac S., Williamson D.W., Huang Y., Mahley R.W. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. JLipid Res 2006, 47:144-153.
-
(2006)
JLipid Res
, vol.47
, pp. 144-153
-
-
Hodoglugil, U.1
Tanyolac, S.2
Williamson, D.W.3
Huang, Y.4
Mahley, R.W.5
-
36
-
-
34548154320
-
Apolipoprotein A-V association with intracellular lipid droplets
-
Shu X., Chan J., Ryan R.O., Forte T.M. Apolipoprotein A-V association with intracellular lipid droplets. JLipid Res 2007, 48:1445-1450.
-
(2007)
JLipid Res
, vol.48
, pp. 1445-1450
-
-
Shu, X.1
Chan, J.2
Ryan, R.O.3
Forte, T.M.4
-
37
-
-
0035977037
-
Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration
-
van der Vliet H.N., Sammels M.G., Leegwater A.C., et al. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. JBiol Chem 2001, 276:44512-44520.
-
(2001)
JBiol Chem
, vol.276
, pp. 44512-44520
-
-
van der Vliet, H.N.1
Sammels, M.G.2
Leegwater, A.C.3
-
38
-
-
33947706206
-
Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family
-
Nilsson S.K., Lookene A., Beckstead J.A., Gliemann J., Ryan R.O., Olivecrona G. Apolipoprotein A-V interaction with members of the low density lipoprotein receptor gene family. Biochemistry 2007, 46:3896-3904.
-
(2007)
Biochemistry
, vol.46
, pp. 3896-3904
-
-
Nilsson, S.K.1
Lookene, A.2
Beckstead, J.A.3
Gliemann, J.4
Ryan, R.O.5
Olivecrona, G.6
|